Blood Work for Nonpregnant 35-Year-Old Female with Breast Discharge
For a nonpregnant 35-year-old female with breast discharge, serum prolactin level is the recommended initial blood test to rule out hyperprolactinemia, followed by thyroid-stimulating hormone (TSH) if prolactin is elevated. 1
Initial Assessment of Breast Discharge
Characterize the Discharge
- Determine if discharge is:
Blood Work Algorithm
Serum Prolactin Level:
- Primary initial blood test for all patients with pathologic nipple discharge 1
- Elevated levels may indicate:
- Pituitary microadenoma
- Medication effect
- Hypothyroidism
- Chronic renal failure
- Cirrhosis
If Prolactin is Elevated:
Imaging Recommendations
After appropriate blood work, imaging is essential for complete evaluation:
- For a 35-year-old female: Both mammography/digital breast tomosynthesis and ultrasound are rated as "usually appropriate" (9/9) by the American College of Radiology 2, 1
- Either mammogram or ultrasound can be used as the initial imaging modality for women 30-39 years 1
Important Clinical Considerations
Risk Assessment
- Pathologic nipple discharge carries a 5-21% risk of underlying malignancy 1
- Risk factors increasing likelihood of malignancy:
Common Pitfalls to Avoid
- Don't dismiss clear fluid discharge as benign without thorough evaluation, even with normal imaging 1
- Don't rely solely on cytology of nipple discharge, as negative results should not stop further evaluation 1
- Don't miss medication-induced causes of nipple discharge 1
Follow-up Recommendations
- If blood work is normal but discharge persists, proceed with recommended imaging 1
- If imaging is negative but discharge continues, further evaluation with MRI breast or ductography may be warranted 1
- Tissue biopsy with core needle biopsy is preferred if imaging identifies suspicious findings 1
Remember that while most nipple discharge is benign (intraductal papilloma being the most common cause), a systematic approach beginning with appropriate blood work is essential to rule out serious underlying conditions that may affect morbidity and mortality 4, 3.